AstraZeneca holds global pitch for Seroquel

Pharma giant AstraZeneca is holding a global pitch for its blockbuster drug Seroquel. It has also hired a new product manager for the brand in the UK.

AstraZeneca: pitch for Seroquel
AstraZeneca: pitch for Seroquel

The drugs company is holding the pitch for its schizophrenia and bipolar disorder drug this week. The account is currently held by Hill & Knowlton.

AstraZeneca confirmed the pitch was taking place but would not disclose further details.

Global sales of Seroquel were $4.5bn last year, making it AstraZeneca's second biggest selling drug.

At the same time, AstraZeneca has hired Reynolds-Mackenzie associate director Tina Batchelor to join its UK team. She has been brought on board as brand comms manager for Seroquel.

Batchelor joins after less than a year at healthcare media relations shop Reynolds-Mackenzie (PRWeek, 11 July 2009). She was hired from Virgo Health and has been working on clients including Roche and Pfizer Oncology.

Reynolds-Mackenzie is currently recruiting for a replacement. The agency has also bolstered its team with the appointment of Abigail Thompson as an account director.

 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in